# Optimizing Patient Usability Experience for Chronic Care

Study · id `cardio:ct-nct03628963` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03628963](<https://clinicaltrials.gov/study/NCT03628963>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03628963

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; High blood pressure; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT03628963. Randomized; single masking; primary purpose supportive care. Start 2018-09 (anticipated); primary completion 2019-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT03628963, source copy `cardio:ctgov-nct03628963-2018-08-22`, retrieved 2026-10-26)
- Planned start: 2018-09 (anticipated) (ClinicalTrials.gov record NCT03628963, source copy `cardio:ctgov-nct03628963-2018-08-22`, retrieved 2026-10-26)
- Primary completion: 2019-01 (anticipated) (ClinicalTrials.gov record NCT03628963, source copy `cardio:ctgov-nct03628963-2018-08-22`, retrieved 2026-10-26)
- Completion: 2019-11 (anticipated) (ClinicalTrials.gov record NCT03628963, source copy `cardio:ctgov-nct03628963-2018-08-22`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT03628963, source copy `cardio:ctgov-nct03628963-2018-08-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03628963-2018-08-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimizing Patient Usability Experience for Chronic Care
- Condition: Chronic Disease
- Intervention (Device): Concerto+
- Lead sponsor: Laval University
- Lead sponsor class: OTHER
- Collaborator: Concerto Health Group Montréal, Qc, Canada
- Collaborator class: UNKNOWN
- Collaborator: International Business Machines (IBM)
- Collaborator class: INDUSTRY
- Collaborator: Vrije Universiteit Brussel
- Collaborator class: OTHER
- Collaborator: Université de Montréal
- Collaborator class: OTHER
- Collaborator: Haute Ecole de Santé Vaud (HESAV), Lausanne, Switzerland
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Laval University (`cardio:org-laval-university`)

## Provenance

Content hash: a32d2b06ea5575ca1a2ce6352b3fe8ca504c0620bf07c02dd5782778e3d85e76
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
